Oncology Central

What is the role of axillary lymph node dissection, if any, in breast cancer treatment?


In 2013, more than 230,000 women were predicted to be diagnosed with breast cancer. Approximately 90% of these patients will present without evidence of distant metastases [1].

The management of the axillary lymph nodes has been the subject of intense study and ongoing debate over the past few decades. Presentation of the European Phase III EORTC AMAROS trial results at the 2013 Annual Meeting of the American Society of Clinical Oncology has reignited the heated debate in this area [2].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.